Filing Details

Accession Number:
0000318306-14-000049
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-29 18:38:47
Reporting Period:
2014-12-24
Filing Date:
2014-12-29
Accepted Time:
2014-12-29 18:38:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318306 Plasmatech Biopharmaceuticals Inc PTBI Pharmaceutical Preparations (2834) 830221517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1349083 Davis B Jeffrey C/O Sco Financial Group Llc
1325 Avenue Of The Americas 27Th Floor
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-24 62,500 $4.00 67,858 No 4 P Indirect By Lake End Capital LLC
Common Stock Acquisiton 2014-12-24 594,801 $4.00 662,659 No 4 J Indirect By Lake End Capital LLC
Common Stock Acquisiton 2014-12-24 300,852 $4.00 963,511 No 4 J Indirect By Lake End Captial LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Lake End Capital LLC
No 4 J Indirect By Lake End Capital LLC
No 4 J Indirect By Lake End Captial LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrants Acquisiton 2014-12-24 62,500 $0.01 62,500 $5.00
Common Stock Series A Cumulative Convertible Preferred Stock Disposition 2014-12-24 238 $4.00 594,801 $4.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,500 2014-12-24 2019-12-24 No 4 P Indirect
0 2014-12-24 2014-12-24 No 4 C Indirect
Footnotes
  1. Jeffrey B. Davis is the managing member of Lake End Capital LLC
  2. Series A Cumulative Convertible Preferred Stock was converted by the Company into common stock on 12/24/2014.
  3. Series A Preferred Stock dividends due and interest due on dividends and liquidated damages were converted into common stock by the company on 12/24/2014.